BAMCO Inc’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-76,630
| Closed | -$4.56M | – | 417 |
|
|
2021
Q2 | $4.56M | Hold |
76,630
| – | – | 0.01% | 327 |
|
|
2021
Q1 | $5.13M | Hold |
76,630
| – | – | 0.01% | 318 |
|
|
2020
Q4 | $4.64M | Hold |
76,630
| – | – | 0.01% | 302 |
|
|
2020
Q3 | $6.05M | Hold |
76,630
| – | – | 0.02% | 267 |
|
|
2020
Q2 | $4.79M | Hold |
76,630
| – | – | 0.02% | 253 |
|
|
2020
Q1 | $4.06M | Hold |
76,630
| – | – | 0.02% | 245 |
|
|
2019
Q4 | $9.27M | Buy |
76,630
+4,000
| +6% | +$575K | 0.04% | 218 |
|
|
2019
Q3 | $13.2M | Buy |
72,630
+6,000
| +9% | +$846K | 0.05% | 188 |
|
|
2019
Q2 | $8.66M | Buy |
66,630
+19,630
| +42% | +$3.52M | 0.03% | 229 |
|
|
2019
Q1 | $11.4M | Buy |
47,000
+10,000
| +27% | +$2.65M | 0.05% | 197 |
|
|
2018
Q4 | $7.05M | Buy |
37,000
+10,016
| +37% | +$2.44M | 0.04% | 213 |
|
|
2018
Q3 | $8.85M | Buy |
26,984
+5,000
| +23% | +$1.53M | 0.04% | 212 |
|
|
2018
Q2 | $6.86M | Buy |
21,984
+1,984
| +10% | +$606K | 0.03% | 218 |
|
|
2018
Q1 | $4.87M | Hold |
20,000
| – | – | 0.02% | 231 |
|
|
2017
Q4 | $6.04M | Buy |
20,000
+1,600
| +9% | +$445K | 0.03% | 225 |
|
|
2017
Q3 | $4.87M | Buy |
18,400
+1,400
| +8% | +$405K | 0.02% | 228 |
|
|
2017
Q2 | $4.48M | Buy |
17,000
+9,504
| +127% | +$2.38M | 0.02% | 231 |
|
|
2017
Q1 | $2.7M | Buy |
7,496
+2,898
| +63% | +$897K | 0.01% | 244 |
|
|
2016
Q4 | $1.33M | Sell |
4,598
-4,627
| -50% | -$1.43M | 0.01% | 268 |
|
|
2016
Q3 | $3.14M | Buy |
9,225
+4,729
| +105% | +$1.73M | 0.02% | 229 |
|
|
2016
Q2 | $1.91M | Buy |
4,496
+3,468
| +337% | +$1.43M | 0.01% | 242 |
|
|
2016
Q1 | $329K | Buy |
1,028
+380
| +59% | +$130K | ﹤0.01% | 277 |
|
|
2015
Q4 | $336K | Sell |
648
-2,552
| -80% | -$942K | ﹤0.01% | 294 |
|
|
2015
Q3 | $938K | Hold |
3,200
| – | – | ﹤0.01% | 307 |
|
|
2015
Q2 | $1.26M | Sell |
3,200
-1,490
| -32% | -$526K | ﹤0.01% | 320 |
|
|
2015
Q1 | $1.42M | Hold |
4,690
| – | – | 0.01% | 316 |
|
|
2014
Q4 | $1.04M | Sell |
4,690
-1,084
| -19% | -$224K | ﹤0.01% | 324 |
|
|
2014
Q3 | $1.34M | Buy |
5,774
+2,796
| +94% | +$704K | 0.01% | 307 |
|
|
2014
Q2 | $658K | Buy |
2,978
+1,298
| +77% | +$289K | ﹤0.01% | 323 |
|
|
2014
Q1 | $530K | Buy |
+1,680
| New | +$535K | ﹤0.01% | 331 |
|
Other funds holding TXMD
CWG
RCMNY
BAMCO Inc's TXMD Position: Q3 2021 in Review
BAMCO Inc sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 76,630 shares — an estimated $4.56M sold.
BAMCO Inc first reported a position in TXMD in Q1 2014 and held it in 30 quarters. The position peaked at $13.2M in Q3 2019. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.
- BAMCO Inc reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
- BAMCO Inc sold 76,630 TherapeuticsMD shares in Q3 2021, an estimated $4.56M.
- BAMCO Inc first reported a position in TherapeuticsMD in Q1 2014 and held it in 30 quarters.
- BAMCO Inc's TherapeuticsMD position peaked at $13.2M in Q3 2019.
- 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.
Based on BAMCO Inc's 13F filing for Q3 2021, filed 12 Nov 2021.